← Back to Screener
PMGC Holdings Inc. Common Stock (ELAB)
Price$3.81
Favorite Metrics
Price vs S&P 500 (26W)-101.20%
Price vs S&P 500 (4W)-8.37%
Market Capitalization$8.13M
All Metrics
Book Value / Share (Quarterly)$273.80
P/TBV (Annual)1.54x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-212.38
Price vs S&P 500 (YTD)-90.82%
Gross Margin (TTM)27.29%
Net Profit Margin (TTM)-907.26%
EPS (TTM)$-170.53
10-Day Avg Trading Volume21.45M
EPS Excl Extra (TTM)$-170.53
EPS (Annual)$-347.46
ROI (Annual)-112.40%
Gross Margin (Annual)66.25%
Cash / Share (Quarterly)$274.25
Revenue Growth QoQ (YoY)-45.79%
ROA (Last FY)-82.88%
Revenue Growth TTM (YoY)141.08%
EBITD / Share (TTM)$-27.34
Operating Margin (TTM)-768.98%
Cash Flow / Share (Annual)$-1139.28
P/B Ratio0.96x
P/B Ratio (Quarterly)0.26x
Net Income / Employee (Annual)$-2
EV / Revenue (TTM)12.69x
Net Interest Coverage (TTM)-46.08x
ROA (TTM)-63.51%
EPS Incl Extra (Annual)$-347.46
Current Ratio (Annual)3.36x
Quick Ratio (Quarterly)1.62x
3-Month Avg Trading Volume4.94M
52-Week Price Return-98.43%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$191.62
P/S Ratio (Annual)4.75x
Asset Turnover (Annual)0.33x
52-Week High$309.12
EPS Excl Extra (Annual)$-347.46
26-Week Price Return-97.22%
Quick Ratio (Annual)2.88x
13-Week Price Return-86.72%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.79x
Enterprise Value$3.628
Asset Turnover (TTM)0.02x
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)1.59x
Pretax Margin (Annual)-251.17%
Cash / Share (Annual)$761.85
3-Month Return Std Dev441.11%
Net Income / Employee (TTM)$-3
ROE (Last FY)-112.40%
Net Interest Coverage (Annual)-7.38x
EPS Basic Excl Extra (Annual)$-347.46
Receivables Turnover (TTM)216.67x
Total Debt / Equity (Quarterly)0.38x
EPS Incl Extra (TTM)$-170.53
ROI (TTM)-75.44%
P/S Ratio (TTM)28.45x
Revenue / Share (Annual)$138.34
Tangible BV / Share (Annual)$737.59
Price vs S&P 500 (52W)-128.26%
Year-to-Date Return-88.18%
5-Day Price Return-20.15%
EPS Normalized (Annual)$-347.46
Net Profit Margin (Annual)-251.17%
Month-to-Date Return-29.88%
EBITD / Share (Annual)$-339.25
Operating Margin (Annual)-246.19%
EPS Basic Excl Extra (TTM)$-170.53
P/TBV (Quarterly)0.38x
P/B Ratio (Annual)0.89x
Inventory Turnover (TTM)0.95x
Pretax Margin (TTM)-914.85%
Book Value / Share (Annual)$1273.34
Price vs S&P 500 (13W)-87.40%
Beta7.08x
Revenue / Share (TTM)$12.99
ROE (TTM)-82.90%
52-Week Low$1.62
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
ELABPMGC Holdings Inc. Common Stock | 28.45x | 141.08% | 27.29% | — | $3.81 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
About
PMGC Holdings Inc operates in medical aesthetics and biopharmaceutical innovation, with a focus on skin aesthetics, obesity treatment, and metabolic health. The company develops and commercializes products addressing these growing market segments.